(CRDO) Credo Technology Holding - Overview
Sector: TechnologyIndustry: Semiconductors | Exchange NASDAQ (USA) | Currency USD | Market Cap: 19.072m | Total Return 114.6% in 12m
Stock: Connectivity, Chips, Cables, IP,
Total Rating 52
Risk 41
Buy Signal -0.92
| Risk 5d forecast | |
|---|---|
| Volatility | 97.0% |
| Relative Tail Risk | -6.61% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.28 |
| Alpha | 58.68 |
| Character TTM | |
|---|---|
| Beta | 3.630 |
| Beta Downside | 1.824 |
| Drawdowns 3y | |
|---|---|
| Max DD | 61.05% |
| CAGR/Max DD | 1.97 |
EPS (Earnings per Share)
Revenue
Risks
Technicals:
volatile
Description: CRDO Credo Technology Holding March 05, 2026
Credo Technology Group Holding Ltd (CRDO) provides high-speed connectivity solutions. These solutions support optical and electrical Ethernet, as well as PCIe applications.
The company offers a range of products, including HiWire active electrical cables, optical PAM4 digital signal processors, low-power line card PHY, and serializer/deserializer (SerDes) chiplets. SerDes technology is critical for high-speed data transmission within data centers. It also provides SerDes IP and integrated circuits.
CRDOs services include predictive integrity link optimization and telemetry, PCIe retimer solutions, and general support and maintenance. The company serves a diverse customer base, including hyperscalers, original equipment manufacturers (OEMs), and original design manufacturers (ODMs). Hyperscalers are large cloud service providers that require massive data center infrastructure.
CRDO operates in the Semiconductors GICS Sub-Industry. Further research on platforms like ValueRay can provide deeper insights into CRDOs market position and financial health.
Headlines to watch out for
- Hyperscaler demand for high-speed connectivity drives revenue growth
- Competition from established semiconductor firms impacts market share
- Supply chain disruptions affect production and delivery timelines
- Geopolitical tensions in Asia risk manufacturing and sales
- PCIe and Ethernet product innovation expands addressable market
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income: 339.8m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.14 > 0.02 and ΔFCF/TA 17.28 > 1.0 |
| NWC/Revenue: 151.8% < 20% (prev 164.4%; Δ -12.59% < -1%) |
| CFO/TA 0.17 > 3% & CFO 339.9m > Net Income 339.8m |
| Net Debt (-1.21b) to EBITDA (349.8m): -3.45 < 3 |
| Current Ratio: 10.82 > 1.5 & < 3 |
| Outstanding Shares: last quarter (186.6m) vs 12m ago 2.27% < -2% |
| Gross Margin: 67.83% > 18% (prev 0.64%; Δ 6.72k% > 0.5%) |
| Asset Turnover: 77.48% > 50% (prev 45.50%; Δ 31.98% > 0%) |
| Interest Coverage Ratio: -1.13 > 6 (EBITDA TTM 349.8m / Interest Expense TTM -162.0m) |
Altman Z'' 7.70
| A: 0.80 (Total Current Assets 1.79b - Total Current Liabilities 165.2m) / Total Assets 2.04b |
| B: 0.11 (Retained Earnings 220.0m / Total Assets 2.04b) |
| C: 0.13 (EBIT TTM 183.0m / Avg Total Assets 1.38b) |
| D: 1.18 (Book Value of Equity 222.1m / Total Liabilities 188.5m) |
| Altman-Z'' Score: 7.70 = AAA |
Beneish M -0.98
| DSRI: 0.44 (Receivables 243.2m/170.7m, Revenue 1.07b/327.5m) |
| GMI: 0.94 (GM 67.83% / 63.71%) |
| AQI: 2.59 (AQ_t 0.06 / AQ_t-1 0.02) |
| SGI: 3.26 (Revenue 1.07b / 327.5m) |
| TATA: -0.00 (NI 339.8m - CFO 339.9m) / TA 2.04b) |
| Beneish M-Score: -0.98 (Cap -4..+1) = D |
What is the price of CRDO shares?
As of March 27, 2026, the stock is trading at USD 96.44 with a total of 5,492,938 shares traded.
Over the past week, the price has changed by -9.94%, over one month by -15.76%, over three months by -33.41% and over the past year by +114.55%.
Over the past week, the price has changed by -9.94%, over one month by -15.76%, over three months by -33.41% and over the past year by +114.55%.
Is CRDO a buy, sell or hold?
Credo Technology Holding has received a consensus analysts rating of 4.62.
Therefore, it is recommended to buy CRDO.
- StrongBuy: 9
- Buy: 3
- Hold: 1
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the CRDO price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 199.4 | 106.7% |
| Analysts Target Price | 199.4 | 106.7% |
CRDO Fundamental Data Overview March 24, 2026
P/E Trailing = 56.8132
P/E Forward = 22.6244
P/S = 17.8555
P/B = 10.3155
Revenue TTM = 1.07b USD
EBIT TTM = 183.0m USD
EBITDA TTM = 349.8m USD
Long Term Debt = 16.3m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 3.34m USD (from shortTermDebt, last fiscal year)
Debt = 12.6m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -1.21b USD (from netDebt column, last quarter)
Enterprise Value = 17.78b USD (19.07b + Debt 12.6m - CCE 1.30b)
Interest Coverage Ratio = -1.13 (Ebit TTM 183.0m / Interest Expense TTM -162.0m)
EV/FCF = 62.68x (Enterprise Value 17.78b / FCF TTM 283.7m)
FCF Yield = 1.60% (FCF TTM 283.7m / Enterprise Value 17.78b)
FCF Margin = 26.56% (FCF TTM 283.7m / Revenue TTM 1.07b)
Net Margin = 31.81% (Net Income TTM 339.8m / Revenue TTM 1.07b)
Gross Margin = 67.83% ((Revenue TTM 1.07b - Cost of Revenue TTM 343.7m) / Revenue TTM)
Gross Margin QoQ = 68.52% (prev 67.55%)
Tobins Q-Ratio = 8.73 (Enterprise Value 17.78b / Total Assets 2.04b)
Interest Expense / Debt = 13.50% (Interest Expense 1.70m / Debt 12.6m)
Taxrate = 1.22% (1.94m / 159.1m)
NOPAT = 180.8m (EBIT 183.0m * (1 - 1.22%))
Current Ratio = 10.82 (Total Current Assets 1.79b / Total Current Liabilities 165.2m)
Debt / Equity = 0.01 (Debt 12.6m / totalStockholderEquity, last quarter 1.85b)
Debt / EBITDA = -3.45 (Net Debt -1.21b / EBITDA 349.8m)
Debt / FCF = -4.26 (Net Debt -1.21b / FCF TTM 283.7m)
Total Stockholder Equity = 1.15b (last 4 quarters mean from totalStockholderEquity)
RoA = 24.65% (Net Income 339.8m / Total Assets 2.04b)
RoE = 29.56% (Net Income TTM 339.8m / Total Stockholder Equity 1.15b)
RoCE = 15.70% (EBIT 183.0m / Capital Employed (Equity 1.15b + L.T.Debt 16.3m))
RoIC = 15.73% (NOPAT 180.8m / Invested Capital 1.15b)
WACC = 18.75% (E(19.07b)/V(19.08b) * Re(18.75%) + D(12.6m)/V(19.08b) * Rd(13.50%) * (1-Tc(0.01)))
Discount Rate = 18.75% (= CAPM, Blume Beta Adj.) -> capped to 17.38%
Shares Correlation 3-Years: 100.0 | Cagr: 5.87%
[DCF] Terminal Value 37.33% ; FCFF base≈283.7m ; Y1≈186.3m ; Y5≈85.2m
[DCF] Fair Price = 9.98 (EV 632.1m - Net Debt -1.21b = Equity 1.84b / Shares 184.4m; r=18.75% [WACC]; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: 80.08 | EPS CAGR: 189.0% | SUE: 1.94 | # QB: 6
Revenue Correlation: 88.56 | Revenue CAGR: 88.83% | SUE: 1.42 | # QB: 6
EPS next Quarter (2026-07-31): EPS=1.08 | Chg7d=+0.056 | Chg30d=+0.216 | Revisions Net=+13 | Analysts=14
EPS next Year (2027-04-30): EPS=4.72 | Chg7d=+0.323 | Chg30d=+0.924 | Revisions Net=+14 | Growth EPS=+42.8% | Growth Revenue=+52.8%
[Analyst] Revisions Ratio: +1.00 (13 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 15.6% (Discount Rate 17.4% - Earnings Yield 1.8%)
[Growth] Growth Spread = +89.8% (Analyst 105.4% - Implied 15.6%)
P/E Forward = 22.6244
P/S = 17.8555
P/B = 10.3155
Revenue TTM = 1.07b USD
EBIT TTM = 183.0m USD
EBITDA TTM = 349.8m USD
Long Term Debt = 16.3m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 3.34m USD (from shortTermDebt, last fiscal year)
Debt = 12.6m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -1.21b USD (from netDebt column, last quarter)
Enterprise Value = 17.78b USD (19.07b + Debt 12.6m - CCE 1.30b)
Interest Coverage Ratio = -1.13 (Ebit TTM 183.0m / Interest Expense TTM -162.0m)
EV/FCF = 62.68x (Enterprise Value 17.78b / FCF TTM 283.7m)
FCF Yield = 1.60% (FCF TTM 283.7m / Enterprise Value 17.78b)
FCF Margin = 26.56% (FCF TTM 283.7m / Revenue TTM 1.07b)
Net Margin = 31.81% (Net Income TTM 339.8m / Revenue TTM 1.07b)
Gross Margin = 67.83% ((Revenue TTM 1.07b - Cost of Revenue TTM 343.7m) / Revenue TTM)
Gross Margin QoQ = 68.52% (prev 67.55%)
Tobins Q-Ratio = 8.73 (Enterprise Value 17.78b / Total Assets 2.04b)
Interest Expense / Debt = 13.50% (Interest Expense 1.70m / Debt 12.6m)
Taxrate = 1.22% (1.94m / 159.1m)
NOPAT = 180.8m (EBIT 183.0m * (1 - 1.22%))
Current Ratio = 10.82 (Total Current Assets 1.79b / Total Current Liabilities 165.2m)
Debt / Equity = 0.01 (Debt 12.6m / totalStockholderEquity, last quarter 1.85b)
Debt / EBITDA = -3.45 (Net Debt -1.21b / EBITDA 349.8m)
Debt / FCF = -4.26 (Net Debt -1.21b / FCF TTM 283.7m)
Total Stockholder Equity = 1.15b (last 4 quarters mean from totalStockholderEquity)
RoA = 24.65% (Net Income 339.8m / Total Assets 2.04b)
RoE = 29.56% (Net Income TTM 339.8m / Total Stockholder Equity 1.15b)
RoCE = 15.70% (EBIT 183.0m / Capital Employed (Equity 1.15b + L.T.Debt 16.3m))
RoIC = 15.73% (NOPAT 180.8m / Invested Capital 1.15b)
WACC = 18.75% (E(19.07b)/V(19.08b) * Re(18.75%) + D(12.6m)/V(19.08b) * Rd(13.50%) * (1-Tc(0.01)))
Discount Rate = 18.75% (= CAPM, Blume Beta Adj.) -> capped to 17.38%
Shares Correlation 3-Years: 100.0 | Cagr: 5.87%
[DCF] Terminal Value 37.33% ; FCFF base≈283.7m ; Y1≈186.3m ; Y5≈85.2m
[DCF] Fair Price = 9.98 (EV 632.1m - Net Debt -1.21b = Equity 1.84b / Shares 184.4m; r=18.75% [WACC]; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: 80.08 | EPS CAGR: 189.0% | SUE: 1.94 | # QB: 6
Revenue Correlation: 88.56 | Revenue CAGR: 88.83% | SUE: 1.42 | # QB: 6
EPS next Quarter (2026-07-31): EPS=1.08 | Chg7d=+0.056 | Chg30d=+0.216 | Revisions Net=+13 | Analysts=14
EPS next Year (2027-04-30): EPS=4.72 | Chg7d=+0.323 | Chg30d=+0.924 | Revisions Net=+14 | Growth EPS=+42.8% | Growth Revenue=+52.8%
[Analyst] Revisions Ratio: +1.00 (13 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 15.6% (Discount Rate 17.4% - Earnings Yield 1.8%)
[Growth] Growth Spread = +89.8% (Analyst 105.4% - Implied 15.6%)